Browse by Speciality Area

Hospital Management
Cardiology
Critical Care
Emergency Medicine
Infectious Disease
Integrative Medicine
Internal Medicine
Neurology
Obstetrics/Gynecology
Primary Care/Hospitalist

Browse by Product Type

Subscription Publications
Books & Study Guides

All Products

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Cardiogenesis (Irvine, Califonrnia), a developer of surgical products for transmyocardial revascularization (TMR) reported FDA approval of its PEARL (Port Enabled Angina Relief using Laser) 5.0 Robotic Delivery System.

At press time … Cardiogenesis wins approval for PEARL TMR hand piece

Name: Relias Media
Price range: $

January 2, 2015

Reprints

Eat Your Fruits and Veggies to Decrease HPV Infection
Immediate vs. Delayed Postpartum Long-Acting Reversible Contraception
Are Deep Contraceptive Implant Removals Predictable?
HPV Vaccination Disparities Among Adult Women in the United States
Doxy-PEP Could Be Prevention Strategy for Some Patients

Post Date: January 2, 2015

Table of Contents

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Subscription Publication

Books & Study Guides

Group & Site Licenses

State CME/CE Requirements